US 12,215,156 B2
HER-2 targeted bispecific compositions and methods for making and using the same
Volker Schellenberger, Palo Alto, CA (US); Eric Johansen, Oakland, CA (US); Angela Henkensiefken, San Jose, CA (US); Darragh Maccann, Magherfelt (GB); James McClory, Banbridge (GB); Philipp Kuhn, Breman (DE); Andre Frenzel, Braunschweig (DE); Bryan Irving, Woodside, CA (US); and Mika Derynck, South San Francisco, CA (US)
Assigned to Amunix Pharmaceuticals, Inc., South San Francisco, CA (US)
Filed by AMUNIX PHARMACEUTICALS, INC., South San Francisco, CA (US)
Filed on Oct. 25, 2023, as Appl. No. 18/494,007.
Application 18/494,007 is a continuation of application No. 18/064,253, filed on Dec. 10, 2022.
Application 18/064,253 is a continuation of application No. PCT/US2021/039006, filed on Jun. 24, 2021.
Claims priority of provisional application 63/196,408, filed on Jun. 3, 2021.
Claims priority of provisional application 63/166,857, filed on Mar. 26, 2021.
Claims priority of provisional application 63/108,783, filed on Nov. 2, 2020.
Claims priority of provisional application 63/077,503, filed on Sep. 11, 2020.
Claims priority of provisional application 63/044,301, filed on Jun. 25, 2020.
Prior Publication US 2024/0076378 A1, Mar. 7, 2024
Int. Cl. C07K 16/28 (2006.01); A61P 35/00 (2006.01); C07K 16/32 (2006.01); C12N 15/70 (2006.01)
CPC C07K 16/2809 (2013.01) [A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C07K 16/32 (2013.01); C12N 15/70 (2013.01); C07K 2317/31 (2013.01); C07K 2319/30 (2013.01); C12N 2800/101 (2013.01)] 8 Claims
 
1. A polypeptide comprising the amino acid sequence of SEQ ID NO: 34.